Continuous glucose monitoring remains difficult to maintain over long periods because most commercial sensors rely on glucose oxidase enzymes that degrade within days or weeks, forcing frequent replacements and increasing cost. Researchers from the Shenzhen Institute of Advanced Technology, the Hong Kong Polytechnic University, and the Korea Advanced Institute of Science and Technology have developed an alternative that avoids enzymes entirely by using a microneedle patch made from glucose responsive hydrogel. The device, called the acoustically readable microneedle patch, or ARMPatch, is designed to work with standard ultrasound probes to measure glucose related swelling in real time without requiring implanted hardware or optical components.
The ARMPatch consists of hydrogel microneedles that absorb interstitial fluid beneath the skin. As glucose levels change, the microneedles swell or contract, altering their length. When placed between the skin and a conventional ultrasound probe, these changes can be detected as shifts in the microneedles’ acoustic profile. Because the system uses only the hydrogel patch and an ordinary ultrasound imager, it avoids the limitations of optical sensing, such as interference and toxicity concerns, and eliminates the need for surgical implantation associated with ultrasound based implants. The researchers describe the patch as an acoustically augmented interface that turns the microneedles into a readable structure for any standard ultrasound device.
Laboratory tests showed that the ARMPatch maintained stable glucose sensing performance for fifty six days, demonstrating durability that surpasses enzyme based sensors. In freely moving animal models, the patch enabled seven days of continuous glucose monitoring, with ultrasound derived readings closely matching those from a commercial glucometer. The strong correlation indicates that the swelling based acoustic measurements can track glucose fluctuations accurately enough for practical use. The researchers emphasize that the patch functions as an accessory for existing ultrasound systems rather than requiring specialized equipment, which could make the technology easier to adopt in clinical or home settings.
The work highlights a new direction for wearable biosensing by using ultrasound as a noninvasive readout method for hydrogel based microneedles. Because the ARMPatch does not rely on enzymes, fluorescent dyes, or implanted electronics, it offers a simpler and potentially longer lasting approach to glucose monitoring. The researchers view the technology as a step toward more accessible and less invasive glucose sensing platforms that can be integrated into routine care. By combining hydrogel microneedles with widely available ultrasound imaging, the ARMPatch introduces a new strategy for continuous glucose monitoring that may reduce maintenance burdens and extend sensor lifespan.
Article from the Chinese Academy of Sciences: Wearable Microneedle Patch Turns Standard Ultrasound Probes into Continuous Glucose Monitors
Abstract in Science Advances: Augmenting ultrasound for continuous glucose monitoring via a wearable acoustically readable microneedle patch
